Use of larotrectinib in a pediatric patient with NTRK-rearranged spindle cell neoplasm and subsequent recurring bone fracture

Pediatr Blood Cancer. 2023 Dec;70(12):e30679. doi: 10.1002/pbc.30679. Epub 2023 Sep 16.

Minji Kim¹, Kyung Taek Hong^{1

2}, Hyun Jin Park^{1

2}, Bo Kyung Kim^{1

2}, Yun Jeong Lee¹, Jung Yoon Choi^{1

2}, Young Hun Choi³, Sung-Hye Park⁴, Han-Soo Kim⁵, Hyoung Jin Kang^{1

2

6}

¹ Department of Pediatrics, Seoul National University College of Medicine, Seoul National University Children's Hospital, Seoul, Republic of Korea.
² Seoul National University Cancer Research Institute, Seoul, Republic of Korea.
³ Department of Radiology, Seoul National University College of Medicine, Seoul National University Hospital, Seoul, Republic of Korea.
⁴ Department of Pathology, Seoul National University College of Medicine, Seoul National University Hospital, Seoul, Republic of Korea.
⁵ Department of Orthopedic Surgery, Seoul National University College of Medicine, Seoul National University Hospital, Seoul, Republic of Korea.
⁶ Wide River Institute of Immunology, Hongcheon, Republic of Korea.

No abstract available

Publication types